Forian (NASDAQ:FORA) Shares Up 1% – Time to Buy?

Shares of Forian Inc. (NASDAQ:FORA) traded up 1% on Tuesday . The company traded as high as $2.06 and last traded at $2.05. 4,898 shares changed hands during trading, a decline of 56% from the average session volume of 11,125 shares. The stock had previously closed at $2.03.

Wall Street Analyst Weigh In

Separately, Roth Mkm reaffirmed a “buy” rating and issued a $5.00 target price on shares of Forian in a report on Thursday, November 14th.

Forian Price Performance

The firm’s 50 day moving average price is $2.05 and its two-hundred day moving average price is $2.26. The firm has a market cap of $63.58 million, a price-to-earnings ratio of -22.78 and a beta of 1.05.

Institutional Investors Weigh In On Forian

A hedge fund recently raised its stake in Forian stock. Canton Hathaway LLC lifted its holdings in shares of Forian Inc. (NASDAQ:FORA) by 2.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 269,650 shares of the company’s stock after buying an additional 6,125 shares during the period. Canton Hathaway LLC owned about 0.87% of Forian worth $582,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 19.25% of the company’s stock.

About Forian

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.